Advertisement

Topics

Herceptin Study Suggests a Shorter, 6-Month Course for Breast Cancer Will Work

16:02 EDT 17 May 2018 | NEJM

In early breast cancer, Herceptin (trastuzumab) may be just as effective with 6 months' treatment as with the standard 12-month course, the New York...

Original Article: Herceptin Study Suggests a Shorter, 6-Month Course for Breast Cancer Will Work

NEXT ARTICLE

More From BioPortfolio on "Herceptin Study Suggests a Shorter, 6-Month Course for Breast Cancer Will Work"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...